diltiazem has been researched along with palmitoylcarnitine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abiko, Y; Hara, A; Hashizume, H | 1 |
| Abiko, Y; Chen, M; Hara, A; Hashizume, H; Xiao, CY | 1 |
1 review(s) available for diltiazem and palmitoylcarnitine
| Article | Year |
|---|---|
[A new approach to the understanding of the mechanism of ischemia/reperfusion damage in the heart and the effects of anti-ischemic drugs].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Circulation; Dilazep; Diltiazem; Energy Metabolism; Humans; Lysophosphatidylcholines; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxygen Consumption; Palmitoylcarnitine; Propranolol; Vasodilator Agents | 1996 |
1 other study(ies) available for diltiazem and palmitoylcarnitine
| Article | Year |
|---|---|
Palmitoyl-L-carnitine modifies the myocardial levels of high-energy phosphates and free fatty acids.
Topics: Adenine Nucleotides; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Creatine Kinase; Diltiazem; Fatty Acids, Nonesterified; Heart; Male; Myocardial Contraction; Myocardium; Palmitoylcarnitine; Phosphocreatine; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spectrophotometry | 1997 |